Completed
Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel
What is being collected
Data Collection
Collected from today forward - ProspectiveOtherNo DNA Sample
Who is being recruted
Over 18 Years
How is the trial designed
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Observational
Study Start: September 2011
Summary
Principal SponsorUniversity Hospital, Geneva
Last updated: August 19, 2014
Sourced from a government-validated database.Claim as a partner
Study start date: September 1, 2011
Actual date on which the first participant was enrolled.The purpose of this ex-vivo study is to estimate the optimal platelet quantity necessary to reverse the antiplatelet effects of prasugrel.
Principal SponsorUniversity Hospital, Geneva
Last updated: August 19, 2014
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
32 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: Acute coronary syndrome Prasugrel loading dose 6-24h before inclusion Exclusion Criteria: Clopidogrel loading dose GPIIbIIIa use within 10 days before inclusion Known congenital thrombopathy and/or congenital coagulation defect
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center